[Numerical considerations for defining a rare disease in China]

S Yu1, H Qiao2, X Zhang3

  • 1School of Medical Humanities and Social Sciences, Harbin Medical University, Harbin 150081, China.

Insights

China needs a clear definition for rare diseases to improve research and drug development. A suggested prevalence of less than 1/10,000 is proposed, considering the nation's population and current conditions.

Area of Science:

  • Public health
  • Genetics
  • Pharmacology

Context:

  • Global rise in rare disease awareness.
  • China's official rare disease lists released in 2018 and 2023.
  • Need for a standardized rare disease definition in China.

Purpose:

  • To propose a prevalence threshold for defining rare diseases in China.
  • To address the importance of a clear definition for research, clinical management, drug development, and health security.

Summary:

  • Rare diseases are a significant global public health concern.
  • Existing Chinese rare disease lists necessitate a refined, population-specific definition.
  • A prevalence of less than 1/10,000 is suggested for China.

Impact:

  • Facilitate targeted research and clinical strategies for rare diseases in China.
  • Guide therapeutic drug development efforts.
  • Enhance national health security by improving rare disease identification and management.